Published in Aliment Pharmacol Ther on August 15, 2006
Evaluation of clinical outcome after laparoscopic antireflux surgery in clinical practice: still a controversial issue. Minim Invasive Surg (2011) 0.78
Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results. Surg Endosc (2015) 0.77
Age and body mass index: significant predictive factors for successful laparoscopic antireflux surgery. Surg Today (2010) 0.75
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14
A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA (2000) 4.92
The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology (1996) 4.69
Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut (2000) 4.32
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut (2008) 3.52
Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol (2005) 2.16
The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther (2009) 1.92
Parkinson disease: the enteric nervous system spills its guts. Neurology (2011) 1.81
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) Gastroenterology (1993) 1.71
Role of viscous guar gums in lowering the glycemic response after a solid meal. Am J Clin Nutr (1994) 1.65
Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas. Groupe d'Etude de l'Oesophage de Barrett. Lancet (1995) 1.59
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.56
Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther (2015) 1.51
An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis. Gastroenterology (1994) 1.49
Endoscopic submucosal dissection in a European setting. A multi-institutional report of a technique in development. Endoscopy (2011) 1.44
Lack of effficacy of botulinum toxin in chronic anal fissure. Aliment Pharmacol Ther (2003) 1.44
Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut (1995) 1.44
Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy (2012) 1.42
Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am J Physiol (1998) 1.39
[Acid-sensitive esophagus: natural history and effect on the quality of life. Comparison with gastroesophageal reflux]. Gastroenterol Clin Biol (2000) 1.39
Changes in enteric neurone phenotype and intestinal functions in a transgenic mouse model of enteric glia disruption. Gut (2005) 1.39
Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut (1997) 1.31
Pathological lesions in colonic biopsies during Parkinson's disease. Gut (2008) 1.29
Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut (2003) 1.25
Enteric glia inhibit intestinal epithelial cell proliferation partly through a TGF-beta1-dependent pathway. Am J Physiol Gastrointest Liver Physiol (2006) 1.24
Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists. Dig Dis Sci (1993) 1.23
Erythromycin enhances fasting and postprandial proximal gastric tone in humans. Gastroenterology (1995) 1.22
Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans. Gut (1996) 1.20
Breath hydrogen response to lactulose in healthy subjects: relationship to methane producing status. Gut (1990) 1.20
Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials. Aliment Pharmacol Ther (1997) 1.18
Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut (2005) 1.17
Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer (1997) 1.16
Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut (1998) 1.14
Colon capsule endoscopy vs. colonoscopy in patients at average or increased risk of colorectal cancer. Aliment Pharmacol Ther (2010) 1.12
Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: a prospective study. Gut (2006) 1.12
[Whole gut irrigation with isotonic mannitol solution in the treatment of gastrointestinal bleeding due to cirrhosis: a controlled study (author's transl)]. Gastroenterol Clin Biol (1978) 1.11
Controlled trial of bowel rest in the treatment of severe acute colitis. Gut (1986) 1.08
Digestion, excretion, and energy value of fructooligosaccharides in healthy humans. Am J Clin Nutr (1996) 1.07
Simultaneous assessment of liquid emptying and proximal gastric tone in humans. Gastroenterology (1993) 1.06
Inter- and intrasubject variability of solid and liquid gastric emptying parameters. A scintigraphic study in healthy subjects and diabetic patients. Dig Dis Sci (1994) 1.05
Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications. Aliment Pharmacol Ther (2014) 1.03
Altered myoelectrical activity in noninflamed ileum of rats with colitis induced by trinitrobenzene sulphonic acid. Neurogastroenterol Motil (1999) 1.02
A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease. Neurogastroenterol Motil (2012) 1.01
Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans. Am J Physiol (1998) 1.01
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1996) 1.00
Alosetron does not affect the visceral perception of gastric distension in healthy subjects. Aliment Pharmacol Ther (1994) 0.99
Low dose omeprazole effects on gastric acid secretion in normal man. Gastroenterol Clin Biol (1987) 0.99
[Does nocturnal monitoring of gastric pH permit the prediction of therapeutic response in severe duodenal ulcer treated with ranitidine?]. Gastroenterol Clin Biol (1986) 0.98
Routine colonic biopsies as a new tool to study the enteric nervous system in living patients. Neurogastroenterol Motil (2009) 0.98
Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding. Hepatology (2000) 0.97
Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut. Pflugers Arch (1997) 0.97
Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet (2000) 0.97
Methodological issues in pharmacokinetic-pharmacodynamic modelling. Clin Pharmacokinet (1998) 0.96
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of solid pancreatic masses: the impact on patient-management strategy. Aliment Pharmacol Ther (2009) 0.96
Review article: respiratory manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2008) 0.96
Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients. Dig Dis Sci (1990) 0.95
Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Aliment Pharmacol Ther (1994) 0.94
Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells. Biochem Biophys Res Commun (1997) 0.94
Colonic fermentation and proximal gastric tone in humans. Gastroenterology (1996) 0.94
Outcome of patients with an implanted artificial anal sphincter for severe faecal incontinence. A single institution report. Int J Colorectal Dis (1998) 0.94
13C-octanoic acid breath test for gastric emptying measurement. Eur J Gastroenterol Hepatol (2000) 0.93
Toxin B of Clostridium difficile activates human VIP submucosal neurons, in part via an IL-1beta-dependent pathway. Am J Physiol Gastrointest Liver Physiol (2003) 0.92
[Detection of endotoxemia in patients with cryptogenic inflammatory enterocolitis]. Gastroenterol Clin Biol (1979) 0.92
Effect of ranitidine on resting pressure and pentagastrin response of human lower esophageal sphincter. Dig Dis Sci (1981) 0.91
[Ischemic colitic in the elderly: predictive factors of gangrenous outcome]. Gastroenterol Clin Biol (1999) 0.91
A French consensus conference on hepatitis C: screening and treatment. J Hepatol (1997) 0.91
Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism. Neurogastroenterol Motil (2008) 0.90
Effects of short-chain fatty acids on gastrointestinal motility. Scand J Gastroenterol Suppl (1997) 0.90
Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology. Aliment Pharmacol Ther (2010) 0.89
Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers. Aliment Pharmacol Ther (2004) 0.89
Inhibition of acetylcholine induced intestinal motility by interleukin 1 beta in the rat. Gut (1996) 0.89
Ambulatory 24-h oesophageal impedance-pH recordings: reliability of automatic analysis for gastro-oesophageal reflux assessment. Neurogastroenterol Motil (2006) 0.89
Colonic transit time of radiopaque markers and rectoanal manometry in patients complaining of constipation. Dis Colon Rectum (1986) 0.88
[Comparative efficacy of omeprazole and cimetidine in the treatment of duodenal ulcer in the acute stage. A French multicenter, controlled therapeutic trial]. Gastroenterol Clin Biol (1987) 0.88
Digestion of raw banana starch in the small intestine of healthy humans: structural features of resistant starch. Br J Nutr (1995) 0.87
Comparison of the effect of different short chain fatty acids on the growth and differentiation of human colonic carcinoma cell lines in vitro. Cell Biol Int (1997) 0.87
Modulation by colonic fermentation of LES function in humans. Am J Physiol Gastrointest Liver Physiol (2000) 0.86
Calcitonin-producing pancreatic somatostatinoma. Gastroenterology (1980) 0.86
Transient pulmonary impairment during attacks of Crohn's disease. Respiration (1981) 0.86
Calcitonin secretion by a pancreatic somatostatinoma. N Engl J Med (1978) 0.86
Involvement of small intestinal motility in blood glucose response to dietary fibre in man. Br J Nutr (1994) 0.85
Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther (2008) 0.85